OrganiGram Holdings (TSX:OGI) Cash-to-Debt : 311.25 (As of Dec. 2023)

View and export this data going back to 2011. Start your Free Trial

What is OrganiGram Holdings Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. OrganiGram Holdings's cash to debt ratio for the quarter that ended in Dec. 2023 was 311.25.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, OrganiGram Holdings could pay off its debt using the cash in hand for the quarter that ended in Dec. 2023.

The historical rank and industry rank for OrganiGram Holdings's Cash-to-Debt or its related term are showing as below:

TSX:OGI' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.24 Med: 2.84 Max: No Debt
Current: 311.25

During the past 10 years, OrganiGram Holdings's highest Cash to Debt Ratio was No Debt. The lowest was 0.24. And the median was 2.84.

TSX:OGI's Cash-to-Debt is ranked better than
91.69% of 1047 companies
in the Drug Manufacturers industry
Industry Median: 0.95 vs TSX:OGI: 311.25

OrganiGram Holdings Cash-to-Debt Historical Data

The historical data trend for OrganiGram Holdings's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

OrganiGram Holdings Cash-to-Debt Chart

OrganiGram Holdings Annual Data

Trend

Apr12

Apr13

Apr14

Aug15

Aug16

Aug17

Aug18

Aug19

Aug20

Aug21

Cash-to-Debt

Get a 7-Day Free Trial

9.65

1.31

0.97

0.63

30.92

OrganiGram Holdings Quarterly Data
	Nov18	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Dec23
Cash-to-Debt	Get a 7-Day Free Trial															29.46	440.27	365.06	294.64	311.25

Competitive Comparison of OrganiGram Holdings's Cash-to-Debt

For the Drug Manufacturers - Specialty & Generic subindustry, OrganiGram Holdings's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

OrganiGram Holdings's Cash-to-Debt Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, OrganiGram Holdings's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where OrganiGram Holdings's Cash-to-Debt falls into.

OrganiGram Holdings Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

OrganiGram Holdings's Cash to Debt Ratio for the fiscal year that ended in Aug. 2021 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	183.843	/	(1.064	+	4.881)
	=	30.92

OrganiGram Holdings's Cash to Debt Ratio for the quarter that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	42.33	/	(0.071	+	0.065)
	=	311.25

OrganiGram Holdings (TSX:OGI) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

OrganiGram Holdings Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of OrganiGram Holdings's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

OrganiGram Holdings (TSX:OGI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » OrganiGram Holdings Inc (TSX:OGI) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

OGI:USA 0OG0:Germany

Address

145 King Street West, Suite 1400, Toronto, ON, CAN, M5H 1J8

Website

https://www.organigram.ca

OrganiGram Holdings Inc is engaged in producing indoor-grown cannabis for patients and adult recreational consumers in Canada. The company has also developed a portfolio of adult-use recreational cannabis brands including Edison, Big Bag o' Buds, SHRED, Monjour, Holy Mountain, and Trailblazer. Tremblant Cannabis, and artisanal craft brand, Laurentian are recent additions to Organigram's existing brand portfolio.

Executives

Donald Geoffrey Machum

Director